Correlation Between CytomX Therapeutics and MacroGenics

Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and MacroGenics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and MacroGenics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CytomX Therapeutics and MacroGenics, you can compare the effects of market volatilities on CytomX Therapeutics and MacroGenics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of MacroGenics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and MacroGenics.

Diversification Opportunities for CytomX Therapeutics and MacroGenics

-0.17

Correlation Coefficient

CytomX Therapeutics  MacroGenics

Good diversification

The 3 months correlation between CytomX and MacroGenics is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and MacroGenics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MacroGenics and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with MacroGenics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MacroGenics has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and MacroGenics go up and down completely randomly.

Pair Corralation between CytomX Therapeutics and MacroGenics

Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 2.89 times more return on investment than MacroGenics. However, CytomX Therapeutics is 2.89 times more volatile than MacroGenics. It trades about 0.13 of its potential returns per unit of risk. MacroGenics is currently generating about 0.02 per unit of risk. If you would invest  96.00  in CytomX Therapeutics on May 3, 2025 and sell it today you would earn a total of  123.00  from holding CytomX Therapeutics or generate 128.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

CytomX Therapeutics  vs.  MacroGenics

CytomX Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CytomX Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, CytomX Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

MacroGenics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in MacroGenics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, MacroGenics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with CytomX Therapeutics and MacroGenics

The main advantage of trading using opposite CytomX Therapeutics and MacroGenics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, MacroGenics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MacroGenics will offset losses from the drop in MacroGenics' long position.

The idea behind CytomX Therapeutics and MacroGenics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.